C
Calibrate
A program designed to improve metabolic health, to drive long-term, sustainable weight loss
About Calibrate
Calibrate is a health-tech startup that operates in the weight loss and wellness market. The company offers a unique approach to sustainable weight loss by focusing on improving metabolic health rather than traditional dieting or calorie counting. Calibrate's program is based on decades of research and combines incremental habit change with medication that works on underlying biology. The company claims to be the first and only program to achieve 15% sustained weight loss in the real world, outside of clinical trials.
Read full description
Calibrate's business model is centered around a subscription-based program that is often covered by employers as a part of their employee wellness initiatives. This means that the company's primary clients are corporations looking to improve the health and wellness of their employees. However, individuals can also subscribe to the program.
The company generates revenue through these subscriptions, and it offers a money-back guarantee if users do not achieve the promised results. This indicates a high level of confidence in the effectiveness of their program.
Calibrate's approach is not restrictive and is easy to maintain, according to its members. The program uses GLP-1s, which work on the same receptors as naturally occurring hormones, to help reduce inflammation, regulate digestion, improve metabolic function, and decrease the risk for cardiovascular disease.
In summary, Calibrate is a health-tech startup offering a unique, science-backed approach to sustainable weight loss and improved metabolic health, primarily serving corporations and their employees.
At a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- New York City, United States
- Employees
- 405
- Open positions
- 10
- Dealroom signal
- 84.0/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Weight Management, Metabolism, Tech for Patients, Hard Tech
- Business model
- Marketplace & ecommerce
- Client focus
- b2b, b2c
Latest news
Press, funding announcements and product moves mentioning Calibrate.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VCOther financing | Nov 2023 | $29M | — | Undisclosed | ↗ |
| EARLY VCOther financing | May 2023 | $0 | — | What If Ventures | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Calibrate is 27K monthly website visits, down 10% over the last three months. Calibrate's team grew 8.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Forerunner Ventures
Kirsten Green
Redesign Health
Series A7 investors entered at this stage
Threshold Ventures
Tiger Global
Founders Fund
Optum Ventures
Samsung Next
Madryn Asset Management
What If Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Calibrate on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Calibrate’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.